# Syndax Pharmaceuticals Inc: Form 8-K, filed Jun 26, 2025

- Company: [Syndax Pharmaceuticals Inc](/companies/sndx.md) (CIK 1395937)
- Form: 8-K
- Filed: 2025-06-26
- Accepted by EDGAR: Jun 26, 2025, 08:54 ET
- Period: 2025-06-24
- Accession: 0000950170-25-090205
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1395937/000095017025090205/sndx-20250624.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1395937/000095017025090205/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1395937/000095017025090205/sndx-20250624.htm

Filed Jun 26, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-090205. Last ingested by Listed: Nov 2, 2026, 16:31 ET. No prices; not investment advice.